08048035968
Premium Exporter of Genuine MABTAS 500mg Injection from India to Singapore – Orchard | Phoenix Exim

1. General Information

MABTAS 500mg Injection contains Rituximab 500mg, a monoclonal antibody medicine used under specialist medical supervision. It is primarily used in certain blood cancers and autoimmune disorders, including non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, and microscopic polyangiitis.

MABTAS is a prescription medicine and is administered by a qualified healthcare professional, generally as an intravenous infusion. It should not be self-administered.

For international pharmaceutical requirements, Phoenix Exim, a medicine exporter from Nagpur, India, can provide product information and export assistance for eligible markets including the USA, UK, Australia, Singapore, Canada, South Korea, and UAE, subject to applicable regulations.

2. Product Information

  • Brand Name: MABTAS 500mg Injection
  • Active Ingredient: Rituximab
  • Strength: 500mg
  • Medicine Class: Monoclonal antibody
  • Route: Intravenous infusion
  • Prescription: Required
  • Storage: Refrigerate at 2°C–8°C; do not freeze.
  • Manufacturer/Marketer: Intas Pharmaceuticals Ltd.

Rituximab targets the CD20 antigen present on B lymphocytes and causes depletion of targeted B cells through immune-mediated mechanisms.

3. Uses of MABTAS 500mg Injection

Depending on the specific indication and local approval, rituximab may be prescribed for:

  • Non-Hodgkin lymphoma (NHL)
  • Chronic lymphocytic leukemia (CLL)
  • Rheumatoid arthritis
  • Granulomatosis with polyangiitis (GPA)
  • Microscopic polyangiitis (MPA)
  • Certain other B-cell or immune-mediated disorders when specifically prescribed by a specialist.

The exact indication, treatment combination, and dosing schedule depend on the patient's diagnosis and medical history.

4. Benefits of This Medicine

When appropriately prescribed, MABTAS 500mg may:

  • Help reduce or control abnormal B-cell activity.
  • Help treat certain B-cell cancers.
  • Help control symptoms and disease activity in selected autoimmune conditions.
  • Reduce the number of targeted CD20-positive B cells in circulation and tissues.

The response and time required to obtain benefits vary considerably between patients and conditions.

5. Side Effects of MABTAS 500mg Injection

Rituximab can cause side effects, ranging from mild to potentially serious. Important risks include:

  • Infusion-related reactions
  • Infections
  • Fever and chills
  • Reduced blood-cell counts
  • Severe allergic reactions
  • Hepatitis B reactivation
  • Severe skin or mucosal reactions
  • Rare serious neurological complications such as progressive multifocal leukoencephalopathy (PML).

Patients should receive appropriate monitoring during treatment and promptly report unusual or severe symptoms.

6. Common Side Effects

Commonly reported effects may include:

  • Headache
  • Weakness or tiredness
  • Fever
  • Chills
  • Nausea
  • Body aches
  • Infusion-related reactions
  • Infections
  • Reduced white blood-cell counts
  • Swelling
  • Abdominal or back pain.

Not every patient experiences these effects, and the side-effect profile can differ according to the condition being treated and other medicines being used.

7. How to Use MABTAS 500mg Injection

MABTAS 500mg is administered only by a doctor or trained healthcare professional, usually through an intravenous infusion. Do not attempt to inject or administer it yourself.

Before treatment, the healthcare team may review:

  • Medical history and allergies
  • Current medicines
  • Blood counts
  • Hepatitis B status
  • Existing infections
  • Heart or other relevant medical conditions.

Premedication with medicines such as an antihistamine, analgesic, and/or corticosteroid may be used depending on the treatment protocol to reduce infusion reactions.

The dose and infusion schedule must always be determined by the treating specialist.

8. How MABTAS 500mg Works

MABTAS contains rituximab, a monoclonal antibody that specifically binds to CD20, a protein found on pre-B and mature B lymphocytes.

After binding to CD20, rituximab promotes destruction of these B cells through mechanisms including complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity. This reduction in B-cell activity helps explain its effectiveness in certain B-cell cancers and autoimmune diseases.

9. Safety Advice for This Medicine

  • Use MABTAS only under specialist medical supervision.
  • Do not self-administer the injection.
  • Tell your doctor about previous allergic or infusion reactions.
  • Inform your doctor about current or recent infections.
  • Hepatitis B screening and monitoring may be required because rituximab can reactivate hepatitis B infection.
  • Tell your doctor if you have liver disease, kidney problems, heart problems, or a history of significant infections.
  • Discuss vaccination timing with your doctor before and during treatment.
  • Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
  • Seek urgent medical attention for breathing difficulty, severe rash, chest discomfort, severe dizziness, high fever, or other serious symptoms during or after infusion.
  • Store the product at 2°C–8°C and do not freeze it.

10. Frequently Asked Questions (FAQs)

Q1. What is MABTAS 500mg Injection?
MABTAS 500mg is a rituximab-containing monoclonal antibody injection used for certain cancers and autoimmune diseases.

Q2. What is the active ingredient in MABTAS 500mg?
The active ingredient is rituximab 500mg.

Q3. Is MABTAS 500mg an antibiotic?
No. It is a monoclonal antibody and is not an antibiotic.

Q4. Can I administer MABTAS 500mg myself?
No. It is administered as an intravenous infusion by a qualified healthcare professional.

Q5. How should MABTAS 500mg be stored?
It should generally be refrigerated at 2°C–8°C and protected from freezing.

Q6. Can MABTAS cause infections?
Yes. Rituximab can increase susceptibility to infections because it reduces B-cell activity.

Q7. Does MABTAS require a prescription?
Yes. It is a prescription medicine and should be used only under appropriate medical supervision.

Q8. What should I tell my doctor before treatment?
Tell your doctor about allergies, infections, hepatitis history, heart problems, vaccinations, pregnancy or breastfeeding, and all medicines you take.

Q9. Is MABTAS used for cancer treatment?
Yes. Rituximab is used for several B-cell malignancies, including certain forms of non-Hodgkin lymphoma and chronic lymphocytic leukemia.

Q10. Are there substitutes for MABTAS 500mg?
Other rituximab 500mg products may be considered as alternatives, but the choice should be made by a qualified healthcare professional.

11. Substitutes for MABTAS 500mg

Potential alternatives containing rituximab 500mg include products such as:

  • Reditux 500mg Injection
  • Lupiximab 500mg Injection
  • Enfiera 500mg Injection
  • Enfeira 500mg Injection

These products may differ in manufacturer, formulation, availability, regulatory approval, and pricing. A substitute should not be selected solely on price or brand name; the treating physician or pharmacist should confirm that the alternative is appropriate.

12. SEO Keywords

  • MABTAS 500mg Injection exporter from India
  • MABTAS 500mg Injection supplier from India
  • MABTAS 500mg Injection wholesale supplier
  • MABTAS 500mg Rituximab exporter
  • Rituximab 500mg Injection exporter India
  • Rituximab 500mg pharmaceutical supplier
  • MABTAS 500mg Injection supplier Nagpur
  • MABTAS 500mg medicine exporter Nagpur India
  • MABTAS 500mg Injection for international supply
  • MABTAS 500mg Injection pharmaceutical export
  • Rituximab 500mg wholesale pharmaceutical supplier
  • MABTAS 500mg Injection export to USA
  • MABTAS 500mg Injection export to UK
  • MABTAS 500mg Injection export to Australia
  • MABTAS 500mg Injection export to Singapore
  • MABTAS 500mg Injection export to Canada
  • MABTAS 500mg Injection export to South Korea
  • MABTAS 500mg Injection export to UAE
  • Genuine MABTAS 500mg Injection supplier
  • Rituximab 500mg B-cell therapy medicine supplier
  • MABTAS 500mg oncology medicine exporter
  • MABTAS 500mg monoclonal antibody supplier
  • Intas MABTAS 500mg pharmaceutical supplier
  • MABTAS 500mg Injection international medicine supplier
  • Phoenix Exim MABTAS 500mg Injection exporter
Aug 20th, 2026 3:19 PM

Keywords